Phoenix Venture Partners

Phoenix Venture Partners LLC is a venture capital firm based in San Mateo, California, with additional offices in Singapore and Cambridge, Massachusetts. Established in 2010, the firm specializes in early-stage investments, focusing on technologies and advanced materials across various sectors. Its investment areas include novel materials, optics, energy generation, healthcare, consumer electronics, and the Internet of Things, among others. Phoenix Venture Partners aims to partner with entrepreneurs to commercialize innovative materials science solutions and provides support in business development, customer partnerships, and operational strategies. The firm primarily invests in North America but also extends its activities to Europe, Asia, Central America, Mexico, and the Caribbean.

John T. Chen

Managing General Partner

Nobuyuki Kambe Ph.D

Co-Founder and Managing General Partner

Avinash Kant Ph.D

Partner

Jennifer Wang

CFO

John Chen Ph.D

Co-Founder and Managing General Partner

Sheng Peng Ph.D

Venture Partner

35 past transactions

Biotia

Series A in 2022
Biotia, Inc. is a health technology company based in New York, founded in 2016. The company specializes in developing software that utilizes DNA sequencing and artificial intelligence to identify and mitigate pathogens and antimicrobial threats before they can cause illness. By leveraging next-generation sequencing and advanced software solutions, Biotia enables clinicians and researchers to enhance patient treatment and improve health outcomes through rapid precision in infectious disease discovery.

Autonomic Materials

Venture Round in 2022
Autonomic Materials, Inc. is a company based in Champaign, Illinois, specializing in self-healing solutions for the coatings industry. Founded in 2005, it designs and manufactures microencapsulated additives that enhance the performance of coatings, adhesives, and sealants. These additives include dual capsule systems utilizing reactive silicone polymers, single capsule systems for epoxy resin curing, and formulations based on oxygen-initiated cross-linking of alkyd resins. The company’s products provide corrosion protection and enable automatic repair of coating damage at the micron level, making them suitable for diverse applications including automotive, military equipment, infrastructure, and consumer paints. By responding to damage as it occurs, Autonomic Materials helps extend the lifespan and performance of various substrates such as metals, wood, concrete, and plastics, thereby serving industries like alternative energy, industrial maintenance, and oil and gas.

Eclipse BioInnovations

Series A in 2022
Eclipse Bioinnovations, founded in 2017, specializes in RNA Next-Generation Sequencing (NGS) technologies developed from research in Professor Gene Yeo's laboratory at UC San Diego. The company focuses on advancing RNA medicines through its Eclipse-Seq platform, which aims to enhance the safety and efficacy of these treatments. One of its key innovations is eCLIP, a unique and efficient technology for identifying RNA binding protein partners and mapping genes. Eclipse offers eCLIP both as a service and a kit, catering to biopharma companies and academic researchers. The technology is adaptable for various RNA types, including siRNA and miRNA, assisting scientists in identifying RNA binding protein targets, thereby facilitating research and the development of new drugs to address a wide range of diseases.

InVivo AI

Seed Round in 2021
InVivo AI is a Montreal-based company founded in 2017 that specializes in using artificial intelligence to enhance pharmaceutical research and development. The company primarily focuses on preclinical toxicology, aiming to improve the efficiency and effectiveness of drug development processes. By leveraging advanced AI technologies, InVivo AI seeks to transform traditional methodologies in the pharmaceutical industry, ultimately contributing to faster and more reliable outcomes in drug safety assessments.

Xandar Kardian

Series A in 2021
Xandar Kardian specializes in advanced occupancy detection solutions for smart building applications, employing a unique radar technology that achieves 99.9% accuracy in presence detection and people counting. Their proprietary system is the first commercial-grade occupancy counting solution capable of measuring foot traffic in open spaces, eliminating the need for traditional cameras. By analyzing micro-vibration patterns generated by human body movements, such as breathing and heartbeat, Xandar Kardian can continuously and autonomously monitor occupant wellness in various environments, including offices, factories, hospitals, and residential settings. This innovative approach ensures accurate monitoring without compromising privacy or requiring wearable devices, making it a valuable tool for enhancing safety and operational efficiency in diverse settings.

FibreCoat

Venture Round in 2021
FibreCoat GmbH produces thermoplastic-coated glass fibres for use in fibre composites on rented glass fibre drawing machines. Direct coating enables new process steps, lower costs and cycle times while at the same time improving technical specifications. The target markets are the automotive and consumer sectors.

Inkbit

Series B in 2021
Inkbit Corporation is a Medford, Massachusetts-based company focused on the research, development, and manufacturing of advanced 3D printers. Founded in 2017, the company has created a next-generation additive manufacturing platform that integrates machine learning and artificial intelligence with material jetting technology. By leveraging the expertise of MIT-trained scientists and engineers in industrial systems, design software, and material science, Inkbit aims to bridge the gap between prototyping and full-scale production. Its platform utilizes machine vision to offer rapid, on-demand manufacturing of multi-material and end-use polymer parts, catering to the needs of demanding industrial applications.

FIGUR8

Series A in 2021
FIGUR8, Inc. is a Boston-based company established in 2016 that specializes in manufacturing wearable sensors designed to measure body movement as a biomarker for musculoskeletal-related conditions. The company also offers a platform that tracks and analyzes musculoskeletal health data, aiming to provide insights into human movement. Founded by a team of engineers, researchers, and designers with backgrounds in wearable computing, digital health, and sports science, FIGUR8 focuses on making advanced movement analysis accessible to a broader audience, moving beyond the elite users to everyday individuals.

Green Theme Technologies

Venture Round in 2021
Green Theme Technologies Inc. is a company based in Albuquerque, New Mexico, that specializes in developing environmentally-friendly chemical technologies for the finishing of textiles and nonwovens. Founded in 2012, the company focuses on innovative treatments that enhance fabric properties, including super-hydrophobic and oleophobic characteristics, as well as dyeing solutions. By prioritizing sustainability, Green Theme Technologies aims to provide effective finishing solutions that minimize environmental impact while improving the functionality of textile products.

Cotsworks

Venture Round in 2021
Manufacturer of rugged optical components and subsystems intended to operate in harsh environments. The company offers a transformation from copper to optical networking with navigation, threat detection, and control systems networking, enabling the industrial-military, and commercial aerospace industry to facilitate operations.

L7 Informatics

Series B in 2021
L7 Informatics provides a workflow management software platform for companies using data-intensive scientific techniques. Advances in next-generation sequencing (NGS) are enabling rapid detection and diagnosis of genetic diseases. It has developed the Enterprise Sequencing Platform (ESP) to accelerate clinical adoption of sequencing and provide a platform for clinicians to easily track, manage, and interpret patient data. It is the first software designed from the ground-up that fully integrates all the requisite components of NGS data flow management, analysis, and reporting, with auditing capability. It was founded in 2012 and is headquartered in Austin, Texas.

Absci

Series E in 2020
AbSci, LLC is a biotechnology company based in Portland, Oregon, specializing in protein production technologies for the biopharmaceutical industry. Founded in 2011, AbSci has developed SoluPro, an innovative expression system utilizing genetically engineered E. coli to facilitate the scalable and cost-effective production of antibodies, antibody fragments, and other soluble recombinant proteins. This technology significantly lowers production costs for both novel and existing biologics, enhancing the efficiency of drug discovery and manufacturing processes. AbSci's therapeutic proteins and antibodies play vital roles in treatments for cancer, hormone-related conditions, autoimmune diseases, and blood disorders. The company's approach integrates biologic drug discovery with cell line development, positioning it as a leader in the advancement of next-generation therapeutics.

WaveFront Dynamics

Series A in 2020
WaveFront Dynamics is a medical device company focused on developing advanced wavefront diagnostic technology for the vision care industry. Its innovative instruments are designed to assess the visual performance of the human eye by measuring changes dynamically over time, rather than relying on a single snapshot. This capability allows for a comprehensive evaluation of the eye, facilitating enhanced treatment planning for complex visual dysfunction. By leveraging dynamic wavefront measurement, the company aims to improve ophthalmic treatment products and ultimately support eye care professionals in delivering better patient outcomes.

Micropore

Series C in 2020
Micropore manufactures reactive plastics which incorporate various powders into a molded matrix. The company's first product uses a CO2 adsorbent powder which is formed into a cartridge to create a revolutionary CO2 adsorbent system used in rebreathing and life support applications. The patented technology is the first major advance in CO2 adsorbent technology in over 100 years, providing superior performance advantages over existing granular adsorbents. It was founded in March of 1997 and is based in Elkton, Maryland.

Crop Enhancement

Series B in 2020
Crop Enhancement LLC is a specialty materials company based in San Jose, California, established in 2011. It focuses on developing innovative formulation technologies that enhance the effectiveness of agricultural chemicals, including pesticides, herbicides, and fertilizers. By utilizing advanced and environmentally friendly chemistry, Crop Enhancement creates proprietary films that modify plant surfaces, improving resistance to pests and diseases. This approach not only helps farmers increase crop yields and profitability but also reduces reliance on synthetic pesticides, promoting sustainable agricultural practices. The company’s technologies facilitate the controlled release of active ingredients, allowing for precise application and minimizing environmental impact.

Absci

Series D in 2020
AbSci, LLC is a biotechnology company based in Portland, Oregon, specializing in protein production technologies for the biopharmaceutical industry. Founded in 2011, AbSci has developed SoluPro, an innovative expression system utilizing genetically engineered E. coli to facilitate the scalable and cost-effective production of antibodies, antibody fragments, and other soluble recombinant proteins. This technology significantly lowers production costs for both novel and existing biologics, enhancing the efficiency of drug discovery and manufacturing processes. AbSci's therapeutic proteins and antibodies play vital roles in treatments for cancer, hormone-related conditions, autoimmune diseases, and blood disorders. The company's approach integrates biologic drug discovery with cell line development, positioning it as a leader in the advancement of next-generation therapeutics.

Broadspot Imaging

Series A in 2018
BroadSpot Imaging Corporation focuses on developing diagnostic medical devices for eye care, specifically in the area of retinal imaging. The company employs advanced imaging technologies and compact, cloud-connected electronics to create cost-effective handheld instruments that replace traditional bulky and expensive diagnostic tools. By integrating AI and machine learning applications, BroadSpot Imaging aims to enhance the efficiency and accessibility of eye care services. Their innovations are designed to meet the growing demand for high-quality diagnostics, particularly as the population ages, allowing eye care professionals to serve more patients effectively and affordably across various medical settings.

Absci

Series C in 2018
AbSci, LLC is a biotechnology company based in Portland, Oregon, specializing in protein production technologies for the biopharmaceutical industry. Founded in 2011, AbSci has developed SoluPro, an innovative expression system utilizing genetically engineered E. coli to facilitate the scalable and cost-effective production of antibodies, antibody fragments, and other soluble recombinant proteins. This technology significantly lowers production costs for both novel and existing biologics, enhancing the efficiency of drug discovery and manufacturing processes. AbSci's therapeutic proteins and antibodies play vital roles in treatments for cancer, hormone-related conditions, autoimmune diseases, and blood disorders. The company's approach integrates biologic drug discovery with cell line development, positioning it as a leader in the advancement of next-generation therapeutics.

ReForm Biologics LLC

Series A in 2018
Comera Life Sciences, formerly known as ReForm Biologics, is a biotechnology company focused on developing advanced formulation technologies for biotherapeutics. Founded in 2014 and based in Woburn, Massachusetts, the company specializes in creating patented, FDA-friendly excipients that enhance the stability and administration of therapeutic biologics. Comera's proprietary platforms enable pharmaceutical companies to produce life-saving medications that are easier to administer, less immunogenic, and more efficient to manufacture, ultimately improving treatment options for fragile patients.

NBD Nanotechnologies

Series B in 2017
NBD Nanotechnologies, Inc. specializes in the manufacture of surface wettability coatings and additives aimed at enhancing the properties of various materials. The company's diverse product portfolio includes offerings such as RepelShell, RepelFlex Antimicrobial, RepelFlex Soft-Touch, NanoGlue, RepelFlex Hard-Coat, Invisiprint, and RepelFlex Leather. These products are designed to modify surface wetting characteristics for applications in glass and plastic, providing benefits such as improved heat transfer through condensation, fog capture and de-misting, and anti-scaling performance. Founded in 2012, NBD Nanotechnologies is headquartered in Lexington, Massachusetts.

Furcifer

Series A in 2017
​Furcifer Inc. is a venture-backed Silicon Valley startup that focuses on developing and manufacturing of next-generation electrochromic films (smart films), with a broad range of applications that include automotive, real estate and electronic display markets.we

Broadspot Imaging

Series A in 2017
BroadSpot Imaging Corporation focuses on developing diagnostic medical devices for eye care, specifically in the area of retinal imaging. The company employs advanced imaging technologies and compact, cloud-connected electronics to create cost-effective handheld instruments that replace traditional bulky and expensive diagnostic tools. By integrating AI and machine learning applications, BroadSpot Imaging aims to enhance the efficiency and accessibility of eye care services. Their innovations are designed to meet the growing demand for high-quality diagnostics, particularly as the population ages, allowing eye care professionals to serve more patients effectively and affordably across various medical settings.

Absci

Series B in 2017
AbSci, LLC is a biotechnology company based in Portland, Oregon, specializing in protein production technologies for the biopharmaceutical industry. Founded in 2011, AbSci has developed SoluPro, an innovative expression system utilizing genetically engineered E. coli to facilitate the scalable and cost-effective production of antibodies, antibody fragments, and other soluble recombinant proteins. This technology significantly lowers production costs for both novel and existing biologics, enhancing the efficiency of drug discovery and manufacturing processes. AbSci's therapeutic proteins and antibodies play vital roles in treatments for cancer, hormone-related conditions, autoimmune diseases, and blood disorders. The company's approach integrates biologic drug discovery with cell line development, positioning it as a leader in the advancement of next-generation therapeutics.

C3Nano

Series D in 2017
C3Nano is the developer of the solution-based, transparent conductive inks and films as direct replacements for indium tin oxide (ITO). C3Nano is the performance leader in Transparent Conductor Films (TCFs) and Activegrid silver nanowire (AgNW) solution-based inks for the touch sensor and display industry. They have raised $37 million in funding to date, which has enabled the company to quickly achieve best in class ink formulations and expanded production capabilities. C3Nano is headquartered in Silicon Valley with an industry-leading manufacturing base in Korea. Founded in 2010, it is headquartered in Hayward, California.

Crop Enhancement

Series B in 2016
Crop Enhancement LLC is a specialty materials company based in San Jose, California, established in 2011. It focuses on developing innovative formulation technologies that enhance the effectiveness of agricultural chemicals, including pesticides, herbicides, and fertilizers. By utilizing advanced and environmentally friendly chemistry, Crop Enhancement creates proprietary films that modify plant surfaces, improving resistance to pests and diseases. This approach not only helps farmers increase crop yields and profitability but also reduces reliance on synthetic pesticides, promoting sustainable agricultural practices. The company’s technologies facilitate the controlled release of active ingredients, allowing for precise application and minimizing environmental impact.

Nohms Technologies

Series B in 2016
NOHMs Technologies, Inc. specializes in the development of advanced lithium-sulfur and lithium-ion battery technologies, targeting a variety of vehicle markets, including spacecraft and electric automobiles. Founded in 2010 and headquartered in Rochester, New York, the company creates innovative materials and manufacturing processes, particularly focusing on enhancing battery performance and safety through its NanoLyte Electrolyte solutions. These new functional ionic liquid materials offer significant improvements in energy capacity and runtime while reducing costs. NOHMs Technologies provides a range of products including electrodes, electrolytes, and separators, as well as solutions for secondary manufacturers, operating under a sales and licensing business model.

Amber Molecular

Series A in 2016
Amber Molecular Inc. develops materials for novel fluorescent organic light-emitting diodes (OLED) emitters. The company was founded in 2017 and is based in Toronto, Canada.

Absci

Series A in 2016
AbSci, LLC is a biotechnology company based in Portland, Oregon, specializing in protein production technologies for the biopharmaceutical industry. Founded in 2011, AbSci has developed SoluPro, an innovative expression system utilizing genetically engineered E. coli to facilitate the scalable and cost-effective production of antibodies, antibody fragments, and other soluble recombinant proteins. This technology significantly lowers production costs for both novel and existing biologics, enhancing the efficiency of drug discovery and manufacturing processes. AbSci's therapeutic proteins and antibodies play vital roles in treatments for cancer, hormone-related conditions, autoimmune diseases, and blood disorders. The company's approach integrates biologic drug discovery with cell line development, positioning it as a leader in the advancement of next-generation therapeutics.
Sentinel Monitoring Systems is at-line and in-line QC systems for ultra-rapid detection of microbial contamination. The Sentinel Online Monitor is a multivariate spectroscopic analyzer for real-time monitoring of bioburden and other target analytes. The Sentinel Sample Collector automatically collects excursion samples identified by online monitors and/or periodic samples during production runs. Other Sentinel products currently in development include automated online endotoxin monitoring and near real-time at-line systems for bioburden and specific organisms. It was founded in 2015 and is based in Tucson, Arizona.

C3Nano

Series C in 2014
C3Nano is the developer of the solution-based, transparent conductive inks and films as direct replacements for indium tin oxide (ITO). C3Nano is the performance leader in Transparent Conductor Films (TCFs) and Activegrid silver nanowire (AgNW) solution-based inks for the touch sensor and display industry. They have raised $37 million in funding to date, which has enabled the company to quickly achieve best in class ink formulations and expanded production capabilities. C3Nano is headquartered in Silicon Valley with an industry-leading manufacturing base in Korea. Founded in 2010, it is headquartered in Hayward, California.

NBD Nanotechnologies

Series A in 2014
NBD Nanotechnologies, Inc. specializes in the manufacture of surface wettability coatings and additives aimed at enhancing the properties of various materials. The company's diverse product portfolio includes offerings such as RepelShell, RepelFlex Antimicrobial, RepelFlex Soft-Touch, NanoGlue, RepelFlex Hard-Coat, Invisiprint, and RepelFlex Leather. These products are designed to modify surface wetting characteristics for applications in glass and plastic, providing benefits such as improved heat transfer through condensation, fog capture and de-misting, and anti-scaling performance. Founded in 2012, NBD Nanotechnologies is headquartered in Lexington, Massachusetts.

Imprint Energy

Series A in 2014
Imprint Energy, Inc. specializes in developing and commercializing innovative zinc-based rechargeable battery technology. The company's flagship product, ZincPoly, overcomes traditional limitations associated with zinc batteries, enabling the creation of rechargeable solutions suitable for a variety of applications. Targeting the small portable electronics market, Imprint Energy focuses on sectors such as mobile accessories, wearable technology, and medical devices. The company's technology promises to deliver performance comparable to lithium batteries while significantly reducing costs and eliminating safety concerns associated with traditional battery designs. Founded in 2010 and headquartered in Alameda, California, Imprint Energy aims to meet the evolving energy demands of contemporary and future electronic devices.

Autonomic Materials

Series B in 2012
Autonomic Materials, Inc. is a company based in Champaign, Illinois, specializing in self-healing solutions for the coatings industry. Founded in 2005, it designs and manufactures microencapsulated additives that enhance the performance of coatings, adhesives, and sealants. These additives include dual capsule systems utilizing reactive silicone polymers, single capsule systems for epoxy resin curing, and formulations based on oxygen-initiated cross-linking of alkyd resins. The company’s products provide corrosion protection and enable automatic repair of coating damage at the micron level, making them suitable for diverse applications including automotive, military equipment, infrastructure, and consumer paints. By responding to damage as it occurs, Autonomic Materials helps extend the lifespan and performance of various substrates such as metals, wood, concrete, and plastics, thereby serving industries like alternative energy, industrial maintenance, and oil and gas.

Vixar

Series B in 2012
Vixar Inc. manufactures short wavelength vertical cavity surface emitting laser (VCSEL) and LED based optical components and subassemblies for sensor and device applications. It serves biomedical, industrial, office product, military, automotive, and consumer industries. The company was founded in 2005 and is based in Plymouth, Minnesota. As of July 2, 2018, Vixar Inc. operates as a subsidiary of OSRAM Licht AG.

C3Nano

Series B in 2012
C3Nano is the developer of the solution-based, transparent conductive inks and films as direct replacements for indium tin oxide (ITO). C3Nano is the performance leader in Transparent Conductor Films (TCFs) and Activegrid silver nanowire (AgNW) solution-based inks for the touch sensor and display industry. They have raised $37 million in funding to date, which has enabled the company to quickly achieve best in class ink formulations and expanded production capabilities. C3Nano is headquartered in Silicon Valley with an industry-leading manufacturing base in Korea. Founded in 2010, it is headquartered in Hayward, California.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.